期刊文献+

急性脑卒中并发院内获得性肺炎192例临床分析 被引量:6

Clinical analysis of 192 cases of nosocomial pneumonia induced by acute stroke
原文传递
导出
摘要 目的探讨急性脑卒巾患者并发院内获得性肺炎的致病菌构成及防治措施。方法回顾性分析我院192例急性脑卒中并发院内获得性肺炎患者的临床资料。结果192例患者呼吸道分泌物培养出13种、116株致病菌,大肠埃希菌、铜绿假单胞菌、肺炎克雷伯菌和金黄色葡萄球菌居前4位,其中革兰阴性菌对亚胺培南敏感,革兰阳性菌则对万古霉素敏感。结论急性脑卒中并发院内获得性肺炎的主要致病菌为大肠埃希菌和铜绿假单胞菌。对患者加强医疗护理措施.加强医院感染的管理,提高急性脑卒巾并发肺炎的预见性,积极控制肺炎有利于降低其死亡率。 Objective To investigate the bacteriological distribution of nosocomial pneumonia induced by acute stroke, and to improve the preventative and therapeutic measures. Methods The clinical data of 192 patients with nosocomial pneumonia induced by acute stroke were analyzed respectively. Results Among the 192 cases, 13 pathogenic microorganisms and 116 strains were cultivated, and the first 4 strains were Escherichia coli, Pseudomonas aeruginosa, Klebsiella and Staphylococcus aureus. Gram-negative bacteria were sensitive to imipenem, and Gram-positive bacteria were sensitive to vancomycin. Conclusion The main pathogens of nosocomial pneumonia in acute stroke patients may be Escherichia coli and Pseudomonas aeruginosa. The measures improving the therapeutic outcome of acute stroke include the enhancement of nursing quality, prevention of cross infection in hospital, increasing predictability of the occurrence of pneumonia induced by acute stroke, and the control of pneumonia.
出处 《中华神经医学杂志》 CAS CSCD 2008年第7期743-745,共3页 Chinese Journal of Neuromedicine
关键词 急性脑卒中 院内获得性肺炎 Acute stroke Nosocomial pneumonia
  • 相关文献

参考文献7

二级参考文献9

共引文献2259

同被引文献35

  • 1王茂林,王改珍.基层综合医院医院感染调查分析[J].临床医药实践,2007,16(11):1095-1096. 被引量:18
  • 2王睿,柴栋,裴斐,方翼,朱曼,王中孝.粘液型铜绿假单胞菌藻酸盐对免疫细胞功能影响[J].中华医院感染学杂志,2004,14(1):25-27. 被引量:2
  • 3李新满,李亚洁,高荣祥.重症脑血管病患者院内获得性肺炎临床观察[J].中国实用神经疾病杂志,2007,10(2):28-30. 被引量:2
  • 4中华医学会呼吸分会.医院获得性肺炎诊断与治疗指南(草案).中华结核和呼吸杂志,1997,22(4):199-201.
  • 5Backman C, Taylor G, Sales A, et al. An integrative review of in- fection prevention and control programs for muhidrug-resistant or- ganisms in acute care hospitals: A socio-ecological perspective [J]. Am J Infect Control, 2011, 39 (5): 368-378.
  • 6Siegel JD, Rhinehart E, Jackson M, et al. Management of mul- tidrug-resistant organisms in health care settings, 2006 [J]. Am J Infect Control, 2007, 35 (10Suppl2): S165-S193.
  • 7Grik K, Dierich MP, Pfaller K, et al. In vitro activity of fosfomy- cin in combination with various antistaphylococcal substances [ J ]. J Antimicrob Chemother,2001,48 ( 2 ) :209 - 217.
  • 8Worlitzsch D,Tarran R,Ulrich M, et al. Effects of reduced mucus oxygen concentration in airway Pseudomonas infections of cystic fibrosis patients[J]. J Clin Invest,2002,109(3) ~317-325.
  • 9Takeoka K, Ichimiya T, Yamasaki T, et al. The in vitro effect of macrolides on the interaction of human po[ymorphonuclear leuko cytes with Pseudomonas aeruginosa in biofilm[J]. Chemotherapy, 1998,44(3) : 190-197.
  • 10Raymond J, Aujard Y. Nosocomial infections in pediatric patients:a European, multicenter prospective study [J].Infect Control Hosp Epidemiol, 2000,(21):260-263.

引证文献6

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部